يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Nisini, R."', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    دورية أكاديمية
    B- and T-cell responses after SARS-CoV-2 vaccination in patients with multiple sclerosis receiving disease modifying therapies. Immunological patterns and clinical implications

    المؤلفون: Iannetta M., Landi D., Cola G., Campogiani L., Malagnino V., Teti E., Coppola L., Di Lorenzo A., Fraboni D., Buccisano F., Grelli S., Mozzani M., Zingaropoli M. A., Ciardi M. R., Nisini R., Bernardini S., Andreoni M., Marfia G. A., Sarmati L.

    المساهمون: Iannetta, M., Landi, D., Cola, G., Campogiani, L., Malagnino, V., Teti, E., Coppola, L., Di Lorenzo, A., Fraboni, D., Buccisano, F., Grelli, S., Mozzani, M., Zingaropoli, M. A., Ciardi, M. R., Nisini, R., Bernardini, S., Andreoni, M., Marfia, G. A., Sarmati, L.

    مصطلحات موضوعية: cd20, covid, fingolimod, igra, natalizumab, ocrelizumab, peptide, t-lymphocyte, adult, b-lymphocyte, bnt162 vaccine, female, human, male, middle aged, multiple sclerosi, sars-cov-2, covid-19, vaccination

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35111162; info:eu-repo/semantics/altIdentifier/wos/WOS:000885019900001; volume:12; firstpage:1; lastpage:11; numberofpages:11; journal:FRONTIERS IN IMMUNOLOGY; http://hdl.handle.net/11573/1635515Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123917417

    الإتاحة: https://doi.org/10.3389/fimmu.2021.796482Test
    http://hdl.handle.net/11573/1635515Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    B- and T-Cell Responses After {SARS}-{CoV}-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications

    المؤلفون: Marco Iannetta, Doriana Landi, Gaia Cola, Laura Campogiani, Vincenzo Malagnino, Elisabetta Teti, Luigi Coppola, Andrea Di Lorenzo, Daniela Fraboni, Francesco Buccisano, Sandro Grelli, Marcello Mozzani, Maria Antonella Zingaropoli, Maria Rosa Ciardi, Roberto Nisini, Sergio Bernardini, Massimo Andreoni, Girolama Alessandra Marfia, Loredana Sarmati

    المساهمون: Iannetta, M, Landi, D, Cola, G, Campogiani, L, Malagnino, V, Teti, E, Coppola, L, Di Lorenzo, A, Fraboni, D, Buccisano, F, Grelli, S, Mozzani, M, Antonella Zingaropoli, M, Rosa Ciardi, M, Nisini, R, Bernardini, S, Andreoni, M, Marfia, Ga, Sarmati, L

    مصطلحات موضوعية: CD20, COVID, IGRA, T-lymphocyte, fingolimod, natalizumab, ocrelizumab, peptides, Adult, B-Lymphocytes, BNT162 Vaccine, Female, Humans, Male, Middle Aged, Multiple Sclerosis, SARS-CoV-2, T-Lymphocytes, COVID-19, Vaccination, Settore MED/17 - MALATTIE INFETTIVE

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35111162; info:eu-repo/semantics/altIdentifier/wos/WOS:000885019900001; volume:12; firstpage:796482; journal:FRONTIERS IN IMMUNOLOGY; http://hdl.handle.net/2108/287855Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123917417

    الإتاحة: https://doi.org/10.3389/fimmu.2021.796482Test
    http://hdl.handle.net/2108/287855Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث